Immunosuppression in Inflammatory Bowel Diseases: Standards, New Developments, Future Trends (Falk Symposium)

Product Description The aetiology of the chronic inflammatory bowel diseases - Crohn's disease and ulcerative colitis - is still enigmatic. The therapeutic approach has therefore traditionally focused on anti-inflammatory principles, including corticosteroids and aminosalicylates. Since a significant proportion of patients is steroid-dependent or refractory and because of the problematic side-effects of long-term systemic steroids, active immunosuppression has gained acceptance in the field. br/ The classical immunosuppressants azathioprine and 6-mercaptopurine have long been evidence-based in IB
cpa11165
cpa11165
cpa11165
cpa11165
cpa11165
cpa11165
cpa11165
cpa11165
cpa11165
cpa11165
My page chakrit is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com

CERTAIN CONTENT THAT APPEARS My page COMES FROM AMAZON SERVICES LLC. THIS CONTENT IS PROVIDED ‘AS IS’ AND IS SUBJECT TO CHANGE OR REMOVAL AT ANY TIME.